SocGen launches rights issue at steep discount
Societe Generale, the French bank reeling from a rogue trading scandal, launched a rights issue at a steep discount on Monday, aiming to raise 5.5 billion euros to bolster its balance sheet.
Sanofi-aventis announced on January 24 that it has extended its tender offer for all outstanding shares of common stock of Genzyme Corporation at $69.00 per share, net to the seller in cash, without interest and less any required withholding taxes.